惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

Microsoft Azure Blog
Microsoft Azure Blog
博客园_首页
Forbes - Security
Forbes - Security
WordPress大学
WordPress大学
P
Proofpoint News Feed
T
Threat Research - Cisco Blogs
L
LINUX DO - 热门话题
L
Lohrmann on Cybersecurity
Spread Privacy
Spread Privacy
D
Darknet – Hacking Tools, Hacker News & Cyber Security
大猫的无限游戏
大猫的无限游戏
博客园 - 三生石上(FineUI控件)
P
Privacy International News Feed
A
About on SuperTechFans
T
Tailwind CSS Blog
I
InfoQ
S
Securelist
云风的 BLOG
云风的 BLOG
罗磊的独立博客
Recent Announcements
Recent Announcements
T
The Exploit Database - CXSecurity.com
B
Blog RSS Feed
V
Visual Studio Blog
Know Your Adversary
Know Your Adversary
The GitHub Blog
The GitHub Blog
Jina AI
Jina AI
腾讯CDC
Cyberwarzone
Cyberwarzone
有赞技术团队
有赞技术团队
AWS News Blog
AWS News Blog
博客园 - 【当耐特】
cs.AI updates on arXiv.org
cs.AI updates on arXiv.org
F
Full Disclosure
S
Secure Thoughts
博客园 - 司徒正美
J
Java Code Geeks
Y
Y Combinator Blog
Google Online Security Blog
Google Online Security Blog
GbyAI
GbyAI
N
News and Events Feed by Topic
Help Net Security
Help Net Security
freeCodeCamp Programming Tutorials: Python, JavaScript, Git & More
Project Zero
Project Zero
T
Tenable Blog
cs.CV updates on arXiv.org
cs.CV updates on arXiv.org
T
Tor Project blog
MyScale Blog
MyScale Blog
Scott Helme
Scott Helme
小众软件
小众软件
K
Kaspersky official blog

Forbes - Healthcare

How to Prevent Domestic Violence Deaths UK Smoking Ban Highlights Debate Over The Proper Function Of Government What To Do When Someone You Love Has Cancer Psychedelic Medicine Goes Mainstream: Breakthrough or Bubble? Humana Profits Eclipse $1 Billion As Medicare Costs Ease Slightly What Are Peptides And Why Is Everyone Talking About Them? Tonsillectomy Doesn’t Lead To Illness, But Tonsillitis Just Might Does Retail Pharmacy Have A Tower Records Problem? Precision Radiation Therapy Could Offer New Hope For Hard-To-Treat Cancers Centene’s Obamacare Enrollment Drops By 2 Million After Congress Strips Subsidies RFK Jr.’s Messaging Could Be Impacting Food And Pharmaceutical Choices Over A Million Road Crash Deaths Annually Prompt $350 Million Investment Breast Cancer Screening Tool Avoids Radiation, Compression, Contrast Large Study Finds Benefits Of Doula Care On Postpartum Outcomes TrumpRx Has Signed Deals With Nearly Every Major Drugmaker. Are Prices Actually Falling? America Can’t Lower Healthcare Costs Without A Moonshot Trump’s Orders Elevate The Medical Status Of Psychedelics And Cannabis Mark Cuban’s Cost Plus Drugs, Humana Partner To Take On Employer Drug Costs Cell, Gene And Specialty Drug Costs Intensify For Health Plans U.S. Tennis Participation Continues Growth. Up 54 Percent Since 2019 New AMA Study Finds Burnout Is Decreasing Among Medical Residents And Fellows Daytime Naps May Be A Sign Of Serious Health Problems, Study Reveals New Antibody Drugs Target Disease From Within Concierge Medicine Was Built For The Few. Here’s How To Open It To The Many Burnout in Medicine Is Still Prevalent, With Emergency Medicine Leading Who Is Actually Qualified To Give Advice On Peptides And Who Isn’t What the 49ers Can Teach Leaders About Handling False And Misleading Narratives Do Older Adults Need Routine Colonoscopies Or Low Thyroid Drugs? Your Period, Your Proteins, Your Health Doctors Say Hegseth’s Flu Vaccine Decision Will Weaken Military Readiness Where Bullets Fly, Malaria Kills Using AI To Personalize Healthcare–Without Losing Patient Trust Progress For Preeclampsia Allowing Our Military To Refuse Flu Vaccination Is A Bad Idea. Here’s Why Can Vaccine Development Weather Political Storms? A Virus From Farmed Seafood Is Causing A New Eye Disease In People Elevance Health Profits Eclipse $1.7 Billion Despite Elevated Costs The UK Passes A Lifetime Smoking Ban. Could America Be Next? There's No Such Thing As Brain Honey UnitedHealth Group Profits Eclipse $6 Billion As Medical Costs Ease AI Is Already Here. The Real Risk In Public Health Is Sitting It Out UnitedHealthcare Reduces Need For Prior Approvals For Patients In Rural America Why No Child Should Have To Sacrifice School To Care For Their Family Oscar Health Launches Consumer Marketplace For Insurance Beyond Its Own Calling The Iconic 867-5309 Now Goes To A Cancer Helpline FDA Lists Xanax Recall. Here’s What You Need To Know What Trump’s Ibogaine Executive Order Means For Veterans With PTSD 20 Years Of Priority Review Vouchers, A Tool For Spurring Needed Drugs Rotavirus Is Surging Across The US — Here’s What Parents Need To Know Leadership Dysfunctional In Healthcare: “Split The Baby” Thinking ‘Bedtime Stacking’ Trends On TikTok. Here Are The Risks Why Do Weight Loss Drugs Work For Some And Not Others? It’s In The Genes Hospital Safety: How to Avoid Medical Errors and Protect Yourself Medicare Can Save $4 Billion On Four Cancer Drugs — Can You Guess Which Ones? After 25 Years Of Consumer-Directed Healthcare, What’s Missing? This Sam Altman-Backed $1.8 Billion Startup Bets AI Can Get Drugs Through Clinical Trials Faster RFK Jr. Pushes To Expand Access To Peptides. A Doctor Explains The Risks How The Trump Administration Is Blocking Access To Home Care Genome Sequencing Solves Rare Disease Mysteries Breakthrough HIV Drug Is Out Of Reach For Many Who Need It Most New Drug Protects Against Life-Threatening Pancreatitis This Pill May Help Pancreatic Cancer Patients Live Longer What Should We Do When The Patient Is Racist? Attention Turns To UnitedHealth Earnings For Signs Of Insurer Rebound New Pancreatic Cancer Drug Nearly Doubles Survival. Here’s What Patients Should Know Why Sex Exists A Novel Approach To The Treatment Of Antibiotic Resistant Infections Democrat-Leaning Plan Takes Aim At Health Plans With New Regulations Trump Administration Weighs Default Medicare Advantage Plans For Seniors An AI System Passed Peer Review. The Scientific Community Isn’t Ready Prior Authorization Reform Is Here — And It Could Change How Millions Get Care The More We Add To U.S. Healthcare, The Worse It Gets How Two Sisters Built A $1 Billion HealthTech Unicorn CDC Delays Reporting Of COVID-19 Vaccine Benefits—Here’s What To Know This Startup Wants To Use AI To Help Digitize History Are Nicotine Pouches Like Zyn And VELO Safe To Use? A Doctor Answers America’s Healthcare Innovation Problem GLP-1 Weight Loss Drugs Are Easy To Get—But Are They Safe? Why Cleveland Clinic Chose This AI Startup To Rewire Key Healthcare Operations Upset About The High Price Of Your Hospital Stay? Medicaid Cuts Might Be To Blame Trump’s New Pharmaceutical Tariffs Will Hit Small Drugmakers Hardest A New Way To Target Metastatic Cancer What A Florida Birth Case Reveals About Post-Dobbs Maternal Healthcare 5 Reasons Why the Medicare Program Can’t Go Broke Lowering Healthcare Costs Without A Disastrous Government-Run Model Promising Study Links Coffee Consumption To Reduced Dementia Risk Gene Regulation May Control How Long We Live Health Insurers Get 2.5% Medicare Rate Hike They Feared Would Be Flat Engineered Antibodies Pry Apart The Most Difficult Viruses Centene Latest Health Insurer To Shakeup Management Ranks 1.6 Million Teens Are Vaping. Health Risks Are Worse Than You Think Increasing Burdens Medical Debt And Bankruptcy Are Uniquely American Medicaid Work Requirements Go Live Soon. Here’s How Many Could Lose Coverage What SpaceX’s IPO Means For The Space Economy Thus Far, Most Favored Nation Drug Prices Have Had Little Impact FDA Approves New Oral Weight Loss Pill Foundayo — Here’s What To Know ‘Medicare By Choice’ Plans Could Work, But More Details Needed Criticism of NFL's Rooney Rule Misses How Hiring Actually Works Navigating Health In The Age Of Misinformation NASA Artemis II astronaut health risks explained
Esteworld: From Cosmetic Surgery To Wellness—And The U.S. A Target
Kevin Rozario · 2026-05-01 · via Forbes - Healthcare
Dr. Burak Tuncer CEO of Esteworld Plastic Surgery Health Group,

Dr. Burak Tuncer, CEO and medical director of Esteworld, consults with a patient on a hair transplant procedure. (Photo by Dinendra Haria/SOPA Images/LightRocket via Getty Images)

SOPA Images/LightRocket via Getty Images

Few countries have reshaped the global medical‑aesthetics market as dramatically as Türkiye, where low‑cost procedures and luxury‑style treatment packages have turned cosmetic surgery into a booming international travel industry.

Leading that global pull is family-owned Esteworld, the plastic surgery health group whose precursor dates back to 1994, and now serves patients from more than 35 countries—including the Netherlands, Germany, the U.K. and U.S.—across its network of centers in Istanbul.

Data from Türkiye’s Ministry of Culture and Tourism and USHAS (International Health Services Inc.) shows that the country receives over 1.5 million international patients annually, with total sector revenue exceeding $2 billion. This growth has continued despite a continuing cost-of-living crisis.

Türkiye’s aesthetic medicine sector has had its share of bad press about botched surgeries, often at practices that are underground and not reputable. However, the combination of price advantage and rising quality means the country continues to see cross-border medical tourism thrive.

Türkiye, like several other markets, is benefiting from rising demand for self-funded medical travel; a global surge in wellness spending—a market that is set to grow to nearly $9.8 trillion by 2029 from $6.8 trillion in 2024, according to research from the Miami-based Global Wellness Institute; and the convergence of healthcare with luxury hospitality models.

Within this context, Esteworld—which is a partner of the American Academy of Aesthetic Medicine (AAAM)—represents a mature institutional player in a rapidly expanding global category. It has several competitors but is the only one integrated across so many cosmetic disciplines.

The business claims a 99.2% satisfaction rate from its 20,000 monthly customers across all disciplines, with the remaining 0.8% largely driven by local Turkish complaints about booking appointments, according to CEO Dr. Burak Tuncer, son of the founder and chairman Dr. Mustafa Tuncer. Turkish residents make up roughly half of all clients, a strong indicator service quality is high in a market where domestic consumers research extensively. “If the Turks choose us, it means we’re doing a good job,” said Tuncer.

Esteworld achieves its high-volume turnaround thanks to integrated medical services—from hair transplants (600,000 in 30 years), rhinoplasty, and mammoplasty to dental aesthetics, botox, fillers and laser treatments—under one roof, or in facilities close by. The group’s main center in Istanbul is the biggest aesthetic clinic in Europe with 70-80 surgeries per day. A new clinic is opening in May and another at the end of the year in the city’s financial center, bringing the total up to six.

Stepping up international expansion

Despite a decade of high double‑digit growth, and more than one million aesthetic treatments under its belt, Esteworld has been establishing offices around the world, with 35 to date including New York and Tokyo—and London, the latest addition last year. Other regional U.K. offices are slated for 2027.

Esteworld's first London office in Covent Garden, with more coming in other U.K. cities soon.

Esteworld

Burak Tuncer describes this shift as Health Tourism 4.0. “We’ve opened those offices to show potential customers that we are right there—before the surgery and after. Any questions or issues can be discussed in their own country for follow up,” he said.

This year’s focus is the U.S., because while Esteworld has brand strength in Europe, it needs more visibility across the Atlantic. “This market is as big as Europe so we want to develop our presence there and we plan to open offices in Miami this year, and Los Angeles, in addition to the existing office in New York,” Tuncer told me. It is part of a positioning strategy to capture a disproportionate share of one of the fastest-growing segments of global healthcare.

Wellness is a new string to Esteworld’s bow

While Esteworld has excelled in cosmetic surgery and medical aesthetics the business noted that many of its customers were staying in their home markets or going to places like Switzerland for well-being and longevity breaks.

Dr. Mustafa Tuncer, Esteworld's chairman, is diversifying the family holding with Well World. (Photo by Dinendra Haria/SOPA Images/LightRocket via Getty Images)

SOPA Images/LightRocket via Getty Images

A few stays later in some of best longevity centers in Europe like Clinique La Prairie in Switzerland sparked the idea for a similar project in Istanbul. Called Well World, it is now being built on the Asia side of Istanbul on the Black Sea coast at Çayırbaşı. “Longevity is a feature of health that focuses on extending well-being before illness arrives,” explained Tuncer, a concept that is gaining traction globally.

The $180 million project, funded by the Tuncer family’s own money, is set to be the biggest longevity club in Europe set on 750 hectares and will open on October 29, 2027, said the chairman Mustafa Tuncer. This is an important date as it’s when Mustafa Kemal Atatürk formally proclaimed the establishment of the Republic of Türkiye as a modern, secular nation‑state in 1923.

A combination of luxury housing, operated on an annual one-week time-share basis (paid via a one-off lifetime membership fee depending whether it is an apartment or a villa), a hotel overlooking the Black Sea surrounded by forest, plus a large clinic on-site to offer a variety of healthcare services, is the model.

The focus is on nature, movement and quality of life and it is expected that a flying car service by AirCar will operate to and from Istanbul to bring customers to the resort when it opens. As Istanbul sits at the intersection of three major regions—Europe, the Middle East, and Asia—it may act as a natural choice for cross-border longevity demand.

An impression of the finished Well World resort on the Black Sea coast of Istanbul, currently under construction.

Well World

The Tuncer family—whose Esteworld and Well World businesses form part of its holding, Tuncer Şirketler Grubu—are yet to make the Forbes Türkiye 100 Rich List. The CEO joked that it could take another five years, but the current strategic moves might speed things up. They signal a shift not just to more volume in terms of new global clients and services, but to a more powerful market positioning. In that time, Tuncer expects to have established surgery centers in Europe—perhaps in the U.K. or France, and one in the U.S. “Our new offices will feed these surgery centers,” said the CEO.

Within the holding, Well World will add new revenue to Esteworld’s €120 million ($141 million) annual sales, probably from 2028, and accelerate the group’s income if the project’s financial calculations work out. Mustafa Tuncer, who provided the figure, has a clear vision, and his son and CEO is acting on it. Their ambition now extends beyond patient volume to category leadership in global wellness.